Vertigo clinical trials

Explore recruiting vertigo clinical trials.

Recruiting vertigo studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vertigo trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, double-blinded, randomized, placebo-controlled trial to compare the effectiveness of intratympanic injections methylPREDnisolone versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial).

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prevention of cardiac surgery-associated acute kidney injury through the use of sodium-glucose cotransporter 2 inhibitors

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial

Sweden, Denmark, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Two-arm, Double-blind, Double dummy, Parallel-group Study for efficacy and safety evaluation of prolonged release formulation of Betahistine PR 48 mg once daily in comparison with conventional release formulation of Betahistine IR 24 mg, twice daily in treatment of adult patients with Menière's disease

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia – a multicentric randomized double-blind placebo-controlled trial (the EMPOWER Study)

Germany, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

TestICUs : Effects of early testosterone gel administration on physical performance in the critically ill: a randomised double blind clinical trial.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Vertigo trials by city

Vertigo in Toronto Vertigo in Vancouver Vertigo in Montreal Vertigo in Calgary Vertigo in Edmonton Vertigo in Ottawa Vertigo in Winnipeg Vertigo in Quebec City Vertigo in Hamilton Vertigo in Kitchener Vertigo in London Vertigo in Halifax Vertigo in New York Vertigo in Los Angeles Vertigo in Chicago Vertigo in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease